# 2C Tech Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/2c-tech-corporation

- Industry: Medical Devices & Equipment
- Headquarters: Irvine, US
- Website: www.2ctechcorp.com
- Total disclosed funding: $10M
- Latest round: Series B (Dec 12, 2019)
- Investors on record: 2

## About

2C Tech Corporation, Inc. specializes in developing innovative medical technology solutions, particularly in the field of eye care, to address critical health challenges.2C Tech Corporation, Inc. is focused on developing advanced medical technologies. The firm is based in Irvine, US. In December 2019, the company successfully raised USD 10 mn in Series B funding from ExSight Ventures and Hoya Corporation, along with other investors. The total amount raised to date stands at USD 10 mn. The company’s founder has a history of entrepreneurship in the medical technology sector, building on prior ventures.The company offers a robust portfolio of products and services designed to address specific needs within its target markets. Their core offerings include advanced diagnostic tools aimed at improving early detection of retinal diseases, tailored to meet the demands of ophthalmologists and healthcare providers. Another notable product is a therapeutic device designed to enhance patient outcomes for those suffering from retinitis pigmentosa. These products have found application across various sectors within the healthcare industry. The company distributes its offerings primarily in North America and parts of Asia, ensuring accessibility and support for local users and businesses.The company employs a structured revenue model based on direct sales and partnerships. Transactions typically occur through online platforms and direct sales to healthcare institutions. Flagship products such as their diagnostic tools and therapeutic devices are central to the company's revenue generation and are available through distribution partners and direct sales channels. Pricing plans for these offerings are strategically developed to cater to different segments, allowing flexibility for healthcare providers while ensuring a steady revenue stream.The company plans to utilize the recent USD 10 mn funding from its Series B round to conduct an initial feasibility analysis for the treatment of retinitis pigmentosa (RP). Additionally, 2C Tech Corporation, Inc. is looking to expand its market presence into Europe and Asia by 2022, targeting partnerships with local distributors to enhance market penetration. Upcoming product launches in the eye care sector are also being developed, with specific timelines to be announced in alignment with ongoing research and funding outcomes.

## Funding rounds

- Series B, Dec 12, 2019, $10M — Hoya Corporation, Exsight ventures

## Investors

- Hoya Corporation — Series B
- Exsight ventures (https://capitalatlas.ai/funds/exsight-ventures) — Series B